Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
02/1996
02/07/1996CN1030922C Process for preparation of new amino acid derivatives
02/06/1996US5489686 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties
02/06/1996US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them
02/01/1996WO1996002522A1 Natriuretic and anti-hypertensive compounds
02/01/1996WO1996002243A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
02/01/1996WO1996002242A1 Use of droloxifene for the treatment of cardiovascular diseases
02/01/1996DE4426601A1 Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri Use of a combination product comprising a competitive progesterone antagonist and a progestin for the manufacture of a medicament for treating endometriosis or leiomyomata uteri of
01/1996
01/31/1996EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/31/1996EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/31/1996EP0694536A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
01/31/1996EP0694300A1 Treatment of impotence
01/31/1996CN1115671A Active component of cordyceps sinensis and its separation method
01/28/1996CA2154745A1 Treatment of impotence
01/26/1996CA2154129A1 Endothelin-antagonizing peptide
01/25/1996WO1996001819A1 Heterocyclic tachykinin receptor antagonists
01/25/1996WO1996001653A1 Methods and compositions for the specific coagulation of vasculature
01/25/1996WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases
01/25/1996CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases
01/24/1996EP0693489A1 Heterocyclic tachykinin receptor antagonists
01/24/1996EP0693062A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases
01/24/1996EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
01/24/1996EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
01/23/1996US5486531 Angina, hypotensive agents, erectile dysfunction
01/23/1996US5486519 Method for treatment of acute renal failure
01/23/1996US5486515 2-fluoroalkyl-1,4-benzoxaxines as potassium channel mediators
01/18/1996WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY
01/18/1996WO1996001118A1 Biochemically balanced peritoneal dialysis solutions
01/17/1996EP0692256A1 Fetus fixation enhancer and diet for mother animals
01/17/1996EP0691985A1 Phosphonomethyldipeptides
01/17/1996EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them
01/17/1996CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them
01/17/1996CN1030718C Superoxide dismutase
01/17/1996CN1030701C Indole derivatives and process for production thereof
01/16/1996US5484811 Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders
01/16/1996US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis
01/16/1996US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis
01/16/1996US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation
01/16/1996US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis
01/16/1996US5484792 Drugs for treatment of urinary incontinence
01/16/1996US5484780 Angiotensin II antagonists
01/11/1996WO1996000738A1 Endothelin antagonists ii
01/11/1996WO1996000732A1 Phosphinic acid derivatives
01/11/1996WO1996000725A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/11/1996WO1996000566A1 A mouldable alum composition
01/11/1996WO1996000503A1 Novel peptides
01/11/1996CA2193367A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/11/1996CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen
01/11/1996CA2190756A1 Endothelin antagonists ii
01/10/1996EP0691342A1 Benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them
01/10/1996EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
01/10/1996EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products
01/10/1996EP0690719A1 Dry mix formulation for bisphosphonic acids
01/10/1996EP0394429B1 Preparation for transdermal application containing gestodene
01/10/1996CN1114564A New medicine for curing vascular system disease
01/09/1996US5482969 Certain N(4-benzoyl-2-phenyl)-3- trifluoro-2-hydroxy-propanamide derivatives
01/09/1996US5482958 Method for treating endometriosis
01/09/1996US5482957 Azole derivatives, process for their preparation and their use
01/09/1996US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds
01/09/1996US5482942 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
01/04/1996WO1996000235A1 Sterol derivatives used for regulation of meiosis
01/04/1996WO1996000205A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
01/04/1996WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
01/04/1996CA2192711A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
01/03/1996EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors
01/03/1996EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
01/03/1996EP0689544A1 Process for production of an imidazole derivative
01/03/1996CN1030609C Methylenebisphosphonic acid derivatives
01/02/1996US5480904 Benzothiophene compound
12/1995
12/29/1995CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them
12/28/1995WO1995035107A1 Endothelin receptor antagonists
12/27/1995EP0688365A1 Fertility regulation with transforming growth factor beta
12/27/1995EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
12/27/1995EP0584159B1 Nutrient preparation
12/26/1995US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them
12/26/1995US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators
12/26/1995US5478856 Styrene derivatives and salts thereof
12/26/1995US5478852 Administering
12/26/1995US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis
12/22/1995WO1994028924A1 Combination of angiotensin converting enzyme inhibitors and aii antagonists
12/22/1995CA2165410A1 Combination of angiotensin converting enzyme inhibitors and all antagonists
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/20/1995EP0687256A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033748A1 Endothelin receptor antagonists
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033477A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995CA2192061A1 Uterine fibroid treatment
12/13/1995EP0686631A1 Pyrimidine derivatives and pharmaceutical composition
12/13/1995EP0686629A2 Cyclohexyl tachykinine receptor antagonists
12/13/1995EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them
12/12/1995US5475015 Benzimidazole derivatives, their preparation and pharmaceutical use
12/12/1995US5474999 Therapeutic amides
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474774 Adhesion inhibiting composition
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists